Conor Tweed, a member of the STAND project team presented at the UCL MRC Clinical Trials Unit on the 24th of November. The the paper he shared with the team was: “Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study.” Jishnu Das, PhD, Ada Kwan, MHS, Benjamin Daniels, MS, Srinath Satyanarayana, MD, Ramnath Subbaraman, MD, Sofi Bergkvist, MS, Ranendra K Das, PhD, Veena Das, PhD, Prof Madhukar Pai, MD published in the November 2015 edition of The Lancet.
Existing studies of the quality of tuberculosis care have relied on recall-based patient surveys, questionnaire surveys of knowledge, and prescription or medical record analysis, and the results mostly show the health-care provider’s knowledge rather than actual practice. No study has used standardised patients to assess clinical practice. Therefore we aimed to assess quality of care for tuberculosis using such patients.
Read the full Lancet article here
Dr Conor Tweed will present the November meeting of the North London TB Journal Club at the UCL Clinical Trials Unit from 1-2pm on Tuesday the 24th November. To reserve your free ticket please follow the link to the November meeting Eventbrite page. Please note that access to the building is restricted so please arrive at least 5 minutes early and reserve a free ticket to ensure you are able to attend.
Date: Tuesday 13th October, 4.00-5.00pm
Location: Lucas Room LG81, LSHTM, Keppel St, London WC1E 7HT.
Dr Helen Fletcher, director of the London School of Hygiene and Tropical Medicine’s TB Centre, will be presenting on:
Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic.
“As someone who spent 11 years developing this vaccine you can imagine I have a thing or two to say about this paper….” says Helen.
The first North London TB Journal Club of the 2015/2016 academic year was kindly hosted by Médecins Sans Frontières UK on the 24th September.
The journal club was chaired by Dr Philipp du Cross with the papers being presented by Dr Catherine Berry. The papers discussed were:
Linezolid for XDR-TB — Final Study Outcomes
Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.